J0174
Injection, lecanemab-irmb, 1 mg
HCPCS · Treatment
Classification
Treatment › Injections and Infusions (nononcologic) › Injection - Monoclonal Antibodies
(CMS RBCS)
First observed
2023
National scale
65.37M services · est. ▲ 3374.2% YoY · 6,300 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 31.38M observed fee-for-service services
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window · National figures — the AZ market is below
- Market sizeThe volume of this code in the market for the year: an all-Medicare estimate scaled from the observed fee-for-service count where one can be drawn, otherwise the narrower count the row names. ~954,172 all-Medicare services · est. (474,045 observed FFS).